Daewoong Pharmaceutical Co. Ltd., of Seoul, South Korea, and Bioalliance Pharma SA, of Paris, inked a supply and license deal for Sitavig (acyclovir Lauriad) for commercialization rights in South Korea. Daewoong also will take over registering the drug, for use in recurrent labial herpes, in that region. Bioalliance is eligible for up-front and milestone payments, and the deal also includes a double-digit royalty rate. Specific financial terms were not disclosed. Read More
HONG KONG – Takeda Pharmaceutical Co. has the green light to manufacture and market its cell cultured influenza vaccines co-developed with Baxter International Inc. The approval is yet another step in Japan's push to boost its influenza preparedness. Read More
HONG KONG — A potent investigational new AIDS drug that has shown promising results as pre-exposure prophylaxis against HIV in macaque monkeys, is now being considered for testing in a clinical trial among high-risk individuals in Hong Kong and elsewhere in China. Read More
HONG KONG – The Global Fund for AIDS, Tuberculosis and Malaria based in Geneva, was in Shanghai last week initiating talks on how to source directly the antiretroviral (ARV) drugs it distributes to patients in need around the world. Read More
HONG KONG – An Indian court has banned exports of a generic cancer drug, giving Bayer Healthcare Pharmaceuticals Inc. a first victory in an ongoing lawsuit to protect the patent of targeted cancer drug Nexavar (sorafenib), one of its star performers co-developed with Onyx Pharmaceuticals Inc. Read More
